Dr Reddys Laboratories Share Price Today - Live Blog for March 04, 2025

The stock of Dr Reddys Laboratories Ltd suffered a -0.11% drop, and it's now trading at ₹1,119.05 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's share price has dropped by -0.00%, a development that warrants careful analysis. Presently trading at ₹1,120.45, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's share price has fallen by -0.28%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,120.60, and market participants are assessing the implications. The stock has a PE ratio of 17.4000, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.15% uptick in its share price. As a result, it's now actively trading at ₹1,123.80 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.09%, and it is currently trading at ₹1,122.65. Additionally, the stock maintains a PE ratio of 17.4000, while the industry PE is 31.6436.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,121.65 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.21% uptick in its share price. As a result, it's now actively trading at ₹1,120.40 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's shares experienced a 0.10% uptick, and they are currently valued at ₹1,117.30, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd witnessed a -0.21% drop in its share price and is currently trading at ₹1,116.40. With the stock's PE at 17.4000 and the industry PE at 31.6436, investors are weighing their options.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.02%, signalling a challenging period. Currently trading at ₹1,118.75, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's share price has dropped by -0.29%, a development that warrants careful analysis. Presently trading at ₹1,117.45, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd witnessed a substantial 0.11% increase in its share price and is currently trading at ₹1,120.25. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd's shares experienced a 0.17% uptick, and they are currently valued at ₹1,118.60, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd's share price rallied by 0.08%, reaching the current market price of ₹1,115.45. This surge is indicative of the stock's recent positive performance.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.05%. At this moment, it's actively trading at ₹1,114.55, presenting an enticing opportunity for those in the market.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.05% increase. Presently, it is actively trading at ₹1,114.80.

The share price of Dr Reddys Laboratories Ltd experienced a -0.29% slump and is currently trading at ₹1,113.65. While the stock maintains a PE ratio of 17.4000, the industry PE is 31.6436, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd plunged by -0.04%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,116.85, but investors are assessing whether this is a temporary dip or a long-term trend.

After a significant 0.01% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,115.95 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.21%, and as of now, it's trading at ₹1,116.95 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's share price rallied by 0.17%, reaching the current market price of ₹1,115.80. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's share price rallied by 0.08%, reaching the current market price of ₹1,114.85. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's stock price surged by 0.04%, reaching the current market value of ₹1,112.80 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.14%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,112.15, and market participants are assessing the implications. The stock has a PE ratio of 17.4000, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.22% upswing, and it's currently trading at ₹1,114.50 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 1.29% recently. As of now, this stock is actively trading at a current market price of ₹1,114.15 per share, attracting attention from investors.